Considering that decreased mRNA expression of histone demethylase UTX was observed in HCC cells treated with sorafenib, these results show that Akt suppression following sorafenib treatment increases H3K27me3 level through decreased EZH2 phosphorylation at Ser21. Here, EZH2 is linked to hepatocellular carcinoma.